Impaired glucose tolerance and other cardiovascular risk factors in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome Source: Eur Respir J 2003; 22: 156-160 Year: 2003
Association between arterial hypertension and impaired glucose tolerance (IGT) in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011
Impact of obstructive sleep apnoea on insulin resistance in nonobese and obese children Source: Eur Respir J 2016; 47: 1152-1161 Year: 2016
Glucose metabolism abnormalities in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012
Impact of obstructive sleep apnoea (OSA) on glucose metabolism Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007
The influence on hyperlipemia and abnormal glucose metabolism in obstructive sleep apnea-hypopnea syndrome (OSAHS) Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Triglyceride-glucose index in non-diabetic, non-obese patients with obstructive sleep apnoea Source: Virtual Congress 2021 – Pathophysiology and clinical consequences of obstructive sleep apnoea Year: 2021
Determinants of hypercapnia in obese obstructive sleep apnea (OSA) patients Source: Eur Respir J 2004; 24: Suppl. 48, 447s Year: 2004
Elevated leptin is associated with impaired glucose tolerance in obstructive sleep apnoea (OSA) Source: Eur Respir J 2006; 28: Suppl. 50, 573s Year: 2006
Cardiovascular and metabolic effects of CPAP in obese obstructive sleep apnoea patients Source: Eur Respir J 2008; 31: 223-225 Year: 2008
Ghrelin and impaired glucose tolerance in obstructive sleep apnoea Source: Eur Respir J 2005; 26: Suppl. 49, 666s Year: 2005
The association of obstructive sleep apnea with insulin resistance in obese Egyptians Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases Year: 2019
Clinical predictors of obesity hypoventilation syndrome in morbidly obese subjects with obstructive sleep apnoea Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I Year: 2015
Cardiovascular risk, insulin resistance and metabolic syndrome in patients with obstructive sleep apnea Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Chronic hypercapnia in morbidly obese patients with obstructive sleep apnea syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 569s Year: 2005
Impact of sleep onset on hemodynamic parameters in obese patients with or without obstructive sleep apnea Source: International Congress 2017 – New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers Year: 2017
In vitro genioglossus function is different in obese and non-obese patients with obstructive sleep apneaSource: Eur Respir J 2001; 18: Suppl. 33, 332s Year: 2001
Differences in levels of systemic inflammation markers between obese subjects with or without obstructive sleep apnea Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010
Oxygen desaturation is associated with diabetes mellitus in patients with obstructive sleep apnoea Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I Year: 2011